Cargando…
National CAPS (Cryopyrin-Associated Periodic Syndrome) Registry
Autores principales: | Bibalo, C, Paloni, G, Lepore, L, Gattorno, M, Finetti, M, Zulian, F, Martini, G, Alessio, M, Cattalin, M, Stabile, A, Rigante, D, Insalaco, A, Manna, R, Gallizzi, R, Obici, L, Cantarini, L, Martino, S, Cionsolini, R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194446/ http://dx.doi.org/10.1186/1546-0096-9-S1-P1 |
Ejemplares similares
-
Canakinumab in the routinary clinical practice in cryopyrin-associated periodic syndromes (CAPS): one year of follow-up
por: Caorsi, R, et al.
Publicado: (2011) -
The schedule of administration of canakinumab in cryopyrin associated periodic syndrome is driven by the phenotype severity rather than the age
por: Caorsi, Roberta, et al.
Publicado: (2013) -
12.3 Long-term follow up of patients with CINCA syndrome: efficacy and tolerability of Anakinra treatment
por: Paloni, G, et al.
Publicado: (2008) -
P02-024 - Clinical impact of V198M mutation in NLRP3 gene
por: Caorsi, R, et al.
Publicado: (2013) -
PReS-FINAL-2232: Long-term follow-up in a national cohort of MKD patients: search for clinical predictors of a spontaneous improvement
por: Doglio, M, et al.
Publicado: (2013)